Nasal Covid vaccine: AIIMS Delhi to conduct Phase 2, 3 clinical trials of Bharat Biotech's shot soon
Bharat Biotech's nasal covid vaccine received regulatory approval for second phase trials in August
New Delhi: The clinical trial of Bharat Biotech's nasal covid vaccine will be held at Delhi's All India Institute of Medical Science (AIIMS) soon. According to a report in ANI, the trial of this nasal vaccine is expected to commence in the next couple of weeks. The approval for this clinical trial has been sent to seek the mandatory permission of the AIIMS Ethics Committee.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more